MD Medical's receipts were removed from the list of securities admitted to trading on the London Stock Exchange, whose listing was the basis for admission of the securities to trading on the Moscow Exchange. However, the company has assumed the obligation to disclose information to the extent and in the manner prescribed by the LSE rules, which will allow it to take advantage of the moratorium on delisting the securities of quasi-Russian companies from Moscow Exchange, which is valid until September 30, 2023.